Eleutheroside D

Eleutheroside D
Product Name Eleutheroside D
CAS No.: 79484-75-6
Catalog No.: CFN98510
Molecular Formula: C34H46O18
Molecular Weight: 742.72 g/mol
Purity: >=98%
Type of Compound: Lignans
Physical Desc.: Powder
Source: The root barks of Eleutherococcus senticosus
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $368/10mg
Eleutheroside has protective effect to myocardial ischemic-reperfusion injury(IRI) in isolated rats.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Int J Mol Sci.2022, 23(20):12516.
  • Cell Death Differ.2021, 1-8.
  • Planta Med.2023, a-2192-2281.
  • Food Engineering Progress2019, 23(3)209-216
  • Archives of Biological sciences2022, 00:21-21
  • Nat Commun.2019, 10(1):2745
  • J Nat Prod.2022, 85(5):1351-1362.
  • Ecol Evol.2022, 12(11):e9459.
  • Integr Med Res.2021, 10(3):100723.
  • Food Chem.2017, 228:301-314
  • Eleutheroside D

    Catalog No: CFN98510
    CAS No: 79484-75-6
    Price: $368/10mg
    Eleutheroside E

    Catalog No: CFN99984
    CAS No: 39432-56-9
    Price: $50/20mg
    (-)-Pinoresinol

    Catalog No: CFN92287
    CAS No: 81446-29-9
    Price: $268/5mg
    (-)-Syringaresinol

    Catalog No: CFN92500
    CAS No: 6216-81-5
    Price: $268/10mg
    Hedyotisol A

    Catalog No: CFN97537
    CAS No: 95732-59-5
    Price: Inquiry(manager@chemfaces.com)
    Hedyotisol B

    Catalog No: CFN97877
    CAS No: 95839-45-5
    Price: Inquiry(manager@chemfaces.com)
    (-)-Syringaresinol 4-(2''-apiosylglucoside)

    Catalog No: CFN99504
    CAS No: 136997-64-3
    Price: $138/20mg
    (+)-Epipinoresinol

    Catalog No: CFN92288
    CAS No: 24404-50-0
    Price: $338/5mg
    Kobusin

    Catalog No: CFN89280
    CAS No: 36150-23-9
    Price: $318/10mg
    (-)-Asarinin

    Catalog No: CFN90144
    CAS No: 133-04-0
    Price: $128/20mg
    Chinese General Practice, 2009, 12(4):292-4.
    Protective Effect of Eleutheroside Preconditioning to Myocardial Ischemic Reperfusion Injury in Isolated Rats[Reference: WebLink]
    To investigate the protective effect of eleutherosid preconditioning to myocardial ischemic-reperfusion injury(IRI) in isolated rats and the dose-effect relationship between eleutheroside preconditioning and the myocardial protection.
    METHODS AND RESULTS:
    Male rat hearts,which were isolated and perfused with Langendorff apparatus,were randomly divided into 5 groups,6 in each.The isolated hearts were subjected to 25 min ischemia and then followed by 30 min reperfusion after 15min stabilization in control group(C).In the eleutheroside preconditioned groups(P1,P2,P3,P4),the hearts were perfused with eleutheroside(30 mg/kg,40 mg/kg,60 mg/kg and 80mg/kg,respectively) for 10 min before ischemia-reperfusion.Left ventricular developed pressure(LVDP),left ventricular end diastolic pressure(LVEDP),maximal rate of increase /decrease of left ventricular pressure(±dp/d tMax),and coronary blood flow(CF) were monitored continuously.And an arrhythmias score was used to quantify the arrhythmias during reperfusion.After reperfusing 30 min reperfusion,as compared with group C,① P2 and P3 groups might increase LVDP、+dp/dtMax and-dp/dtMax more significantly(P0.05);②P2 and P3 groups might raise CF more significantly(P0.01);③P2 and P3 groups had lower arrhythmia scores(P0.05).
    CONCLUSIONS:
    Eleutheroside preconditioning has a dose-effect on IRI of isolated rat hearts.
    Evid Based Complement Alternat Med . 2013;2013:934183.
    Eleutheroside E, An Active Component of Eleutherococcus senticosus, Ameliorates Insulin Resistance in Type 2 Diabetic db/db Mice[Pubmed: 23690865]
    Abstract Eleutheroside E (EE), a principal component of Eleutherococcus senticosus (ES), has anti-inflammatory and protective effects in ischemia heart. However, it is unknown whether it ameliorates insulin resistance and reduces hyperglycemia in diabetes. This study investigated the effect of EE-containing ES extracts, as well as EE, on hyperglycemia and insulin resistance in db/db mice. EE increased the insulin-provoked glucose uptake in C2C12 myotubes. Moreover, EE improved TNF- α -induced suppression of glucose uptake in 3T3-L1 adipocytes. Five-week-old db/db mice were fed a diet consisting of ES extract or EE for 5 weeks. Both were effective in improving serum lipid profiles and significantly decreased blood glucose and serum insulin levels. ES and EE supplementation effectively attenuated HOMA-IR. Glucose tolerance and insulin tolerance tests showed that EE increased insulin sensitivity. Immunohistochemical staining indicated that ES and EE protected pancreatic alpha and beta cells from diabetic damage. In addition, ES and EE improved hepatic glucose metabolism by upregulating glycolysis and downregulating gluconeogenesis in obese type 2 diabetic mice. These data suggest that EE mediates the hyperglycemic effects of ES by regulating insulin signaling and glucose utilization. The beneficial effects of EE may provide an effective and powerful strategy to alleviate diabetes.
    Pueroside C

    Catalog No: CFN95156
    CAS No: 112343-16-5
    Price: $368/5mg
    N-Methylcorydalmine

    Catalog No: CFN95204
    CAS No: 81010-29-9
    Price: $398/5mg
    (-)-Cadin-4,10(15)-dien-11-oic acid

    Catalog No: CFN95246
    CAS No: 1124353-23-6
    Price: $318/5mg
    Narirutin 4'-glucoside

    Catalog No: CFN95421
    CAS No: 17257-22-6
    Price: $318/10mg
    Bergamjuicin

    Catalog No: CFN95422
    CAS No: 2376307-20-7
    Price: $318/5mg
    Naringenin 7-O-gentiobioside

    Catalog No: CFN95435
    CAS No: 104154-33-8
    Price: $368/5mg
    Ganoderenic acid K

    Catalog No: CFN95469
    CAS No: 942950-94-9
    Price: $318/10mg
    Giganteone C

    Catalog No: CFN95484
    CAS No: 1071223-56-7
    Price: $318/10mg
    Regaloside I

    Catalog No: CFN95525
    CAS No: 126239-78-9
    Price: $318/5mg
    Methyl lucidenate A

    Catalog No: CFN95583
    CAS No: 105742-79-8
    Price: $318/5mg